Logger Script
바로가기 및 건너띄기 링크
본문 바로가기
주메뉴 바로가기

홈논문 주제별검색 기관별검색

코로나-19 환자의 후유증 한약 치료에 대한 고찰

Review on Herbal Medicine Treatment for Late Complications of COVID-19 Patients

이경은 (우석대학교 한의과대학) ,   정선형 ( 우석대학교 한의과대학) ,   정민정 ( 우석대학교 한의과대학) ,   최유민 ( 우석대학교 한의과대학) ,   송미덕 ( 경희한의원) ,   장인수 ( 우석대학교 한의과대학)

원문저장 스크랩 EndNote

코로나-19 환자의 후유증 한약 치료에 대한 고찰 - 저널명, 기관명, ISSN, 발행일, 권호, 페이지, 조회수, ISBN 정보 안내
저널명 대한한방내과학회지  기관명 대한한방내과학회 
ISSN 12269174  발행일 2021-03-30 
권호 제 42권 제 1호  페이지 53-66 
조회수 389  ISBN  

초록

한글초록

한글 초록 없음

영어초록

Objective:
The purpose of this study was to collect and evaluate evidence of herbal medicine treatments for the residual effects of COVID-19.
Methods:
Nine electronic databases, namely PubMed, Science Direct, CINAHL, CNKI, Wanfang, J-STAGE, CiNii, OASIS, and Science ON, were searched with the following keywords: ‘COVID-19’; ‘sequelae’; ‘Convalescence’ for ‘P (Population)’ and ‘Medicine, Chinese Traditional’; ‘Korean medicine’; ‘Herbal medicine’ for ‘I (Intervention)’. For the selected studies, various clinical data were extracted including patient symptoms, pattern identification, herbal medicines prescribed, and treatment results.
Results:
A total of nine clinical studies were identified (two case control trials; one case series; and six case reports). Various residual symptoms had been detected in the recovery stage of COVID-19 with the most commonly used pattern identifications being deficiency in both lung and spleen and in both qi and yin. Any herbal medicine prescriptions were written using these patterns. We found several reports of the positive effect of herbal medicines in that it improved symptoms, lung function, and lung inflammation. No adverse events were reported.
Conclusions:
The results indicate that treatment with herbal medicines has a possible therapeutic effect on the residual symptoms of COVID-19. Large-scale studies are necessary to confirm the effectiveness of these approaches.

열기 접기

참고문헌

이 논문의 참고문헌이 24 건이 있습니다.

1. Angelo C, Roberto B, Francesco L 외 1 명, Persistent symptoms in patients after acute COVID-19, JAMA (2020), Vol 324-6, 603-605 ref
2. Jang SB, Kim DS, Yi EH 외 3 명, Telemedicine and the use of Korean medicine for patients with COVID-19 in South Korea: observational study, JMIR Public Health Surveil (2021), Vol 7-1, e20236 ref
3. Li L, Gou CY, Li XM 외 3 명, et al., Effects of Chinese medicine on symptoms, syndrome evolution, and lung inflammation absorption in COVID-19 convalescent patients during 84-day follow-up after hospital discharge: a prospective cohort and nested case-control study, Chin Journal Integr Med (2021), 1-7 ref
4. Shi S, Fang Z, Xiong K 외 3 명, et al., Clinical studies of comprehensive TCM treatment to 30 cases of Qi Yin deficiency type of COVID-19 in its recovery period, Jiangsu Journal TCM (2021), Vol 53-1, 25-28 ref
5. Li Y, Shi S, Yao Y 외 2 명, Clinical characteristics of 86 cases COVID-19 convalescent patients, Journal Liaoning Univ TCM (2020), Vol 22-9, 122-125 ref
6. Jia X, Jiang T, Zhang B 외 3 명, et al., Traditional Chinese medicine treatment for COVID-19 in recovery stage, Shandong Journal TCM (2020), Vol 39-9, 897-902 ref
7. Xiong F, Gong P, Liu Y 외 1 명, Feasibility analysis of Chinese medicine for activate blood and resolve stasis on the recovery stage treatment of COVID-19, Research of Integrated Traditional Chinese and Western Medicine (2020), Vol 12-4, 272-275 ref
8. Cong X, Cao Q, He Y 외 2 명, Medication thinking and method of pulmonary fibrosis treatment in recovery stage of COVID-19, Acta Chinese Medicine (2020), Vol 35-267, 1583-1586 ref
9. Huang L, Chen M, Tao W 외 3 명, et al., Traditional Chinese medicine diagnosis and treatment protocol for COVID-19 in recovery period and the case analysis, Fujian Journal TCM (2020), Vol 51-4, 4-7 ref
10. Zhao W, Han G, Wang X 외 3 명, et al., Experience on the traditional Chinese medicine treatment of mild and ordinary type of COVID-19 in middle and recovery period, Shanxi Journal TCM (2020), Vol 36-4, 36-37
11. Wen L, Wan K, Suai Y 외 1 명, Application of Qingzao Yangrong decoction to convalescent patients with COVID-19, Pharmacology and Clinics of Chinese Materia Medica (2020), Vol 36-2, 61-63 ref
12. Huang C, Huang L, Wang Y 외 3 명, et al., 6-month consequences of COVID-19 in patients discharged from hospital a cohort study, Lancet (2021), Vol 397-10270, 220-232 ref
13. Jeong S, Lee K, Jeong M 외 2 명, A review on the treatment of herbal Medicine for asymptomatically infected COVID-19 patients, Journal Korean Med (2021), Vol 42-1, 99-109 ref
14. Tenforde MW, Kim SS, Lindsell CJ 외 3 명, et al., Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020, MMWR Morb Mortal Wkly Rep (2020), Vol 69-30, 993-998 ref
15. Laura P, Anna A, Donna LM 외 3 명, et al., SARS-CoV-2 infects the brain choroid plexus and disrupts the blood-CSF barrier in human brain organoids, Cell Stem Cell (2020), Vol 27-6, 951-961 ref
16. Zsuzsanna V, Andreas JF, Peter S 외 3 명, et al., Endothelial cell infection and endotheliitis in COVID-19, Lancet (2020), Vol 295-10234, 1417-1418 ref
17. Rapkiewicz AV, Mai X, Carsons SE 외 3 명, et al., Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series, EClinicalMedicine (2020), Vol 24, 100434 ref
18. Tripathi MK, Singh P, Sharma S 외 3 명, Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor, Journal Biomol Struct Dyn (2020), 1-14 ref
19. Kim TY, Jeon SE, Jang YH 외 3 명, et al., Platycodin D prevents both Iysosome- and TMPRSS2-driven SARS-CoV-2 infection in vitro by hindering membrane fusion, BioRxiv (2020) ref
20. Huang J, Tao G, Liu J 외 3 명, Current Prevention of COVID-19: Natural Products and Herbal Medicine, Front Pharmacol (2020), Vol 11, 588508 ref
21. Hui DS, Joynt GM, Wong KT 외 3 명, et al., Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors, Thorax (2005), Vol 60-5, 401-409 ref
22. Jang I, Baik Y, Bae S 외 3 명, An Overview of the Herbal Remedies for Severe Acute Respiratory Syndrome (SARS) in WHO Official Report (2004), Journal Korean Med (2009), Vol 30-3, 571-581
23. National health commission & national administration of traditional Chinese medicine, Diagnosis and treatment protocol for novel coronavirus pneumonia (trial version 7), Chinese Medical Journal (2020), http://www.gov.cn/zhengce/zhengceku/2020-03/04/content_5486705.html
24. Arita R, Ono R, Saito N 외 3 명, et al., Kakkonto, shosaikoto, Platycodon grandiflorum root, and gypsum (a Japanese original combination drug known as saikatsugekito): Pharmacological review of its activity against viral infections and respiratory inflammatory conditions and a discussion of its applications to COVID-19, Traditional & Kampo Medicine (2020), Vol 7-3, 115-127 ref

열기 접기